Shukla Sanjay - Insider Non-Derivative Transactions at aTYR PHARMA INC (LIFE) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on May 31, 2024, Shukla Sanjay's relationship to aTYR PHARMA INC (LIFE) is Director,Officer (President and CEO), and currently has 136,548 shares of Common stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other LIFE insiders.
Data Source: SEC.
Shukla Sanjay - Insider Non-Derivative Transactions of LIFE Common stock
Shukla Sanjay - Insider Non-Derivative Transactions at LIFE
Items per page:
0 of 0
Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
---|---|---|---|---|
Jun 1, 2024 | P -- (Common Stock) | 20000 | 1.81 | 136548 |
Feb 6, 2024 | M -- (Common stock) | 10375 | 0 | 116548 |
Dec 13, 2023 | P -- (Common Stock) | 12000 | 1.18 | 106173 |
Dec 12, 2023 | P -- (Common Stock) | 3000 | 1.17 | 94173 |
Nov 14, 2023 | P -- (Common Stock) | 13578 | 1.11 | 91173 |
Nov 11, 2023 | P -- (Common Stock) | 1422 | 1.14 | 77595 |
Jul 29, 2023 | P -- (Common Stock) | 15000 | 2.01 | 76173 |
Feb 4, 2023 | M -- (Common stock) | 10375 | 0 | 61173 |